Cystic Fibrosis

The Daily Biotech Pulse: Ampio Falls On Knee Osteoarthritis Trial Update, AstraZeneca's COVID-19 Antibody Data, CureVac-GSK's Bivalent COVID-19 Vaccine Data

Eloxx Shares Slump As Phase 2 Cystic Fibrosis Trial Data Fails To Cheer Investors

Calithera Posts Early-Data For Arginase Inhibitor In Cystic Fibrosis Trial

Eloxx Shares Slump As Phase 2 Cystic Fibrosis Trial Data Fails To Cheer Investors

Calithera Posts Early-Data For Arginase Inhibitor In Cystic Fibrosis Trial

Eloxx Stock Moves Higher On Fast Track Tag For Cystic Fibrosis Candidate

Why AzurRx Stock Is Trading Higher After MS1819 Combo Therapy Data?

Eloxx Stock Moves Higher On Fast Track Tag For Cystic Fibrosis Candidate

Why AzurRx Stock Is Trading Higher After MS1819 Combo Therapy Data?

Eloxx Pharma Sees Data Readout From First Four Arms Of Cystic Fibrosis Study By End Of 2021

Arrowhead Stock Drops After RNAi Therapeutic Shows Lung Inflammation In Animal Models

Cystic Fibrosis Recent News

Vertex Pharma's Trikafta Triplet Therapy Wins FDA Approval For Expanded Use In Children 6-11 Years With Cystic Fibrosis

Concert Pharma Sells VX-561-Related Milestones To Vertex For $32M

AzurRx BioPharma Stock Gains On Positive MS1819-PERT Combo Data In Pancreatic Insufficiency

AzurRx's Stock Falls After MS1819 For Pancreatic Insufficiency Flunks Mid-Stage Study

Translate Bio Shares Drop After Its mRNA-Based Cystic Fibrosis Candidate Did Not Improve Lung Function

Translate Bio Inc (NASDAQ: TBIO) revealed its second interim analysis from Phase 1/2 clinical trial evaluating MRT5005 in patients with cystic fibrosis (CF).

Eloxx Pharma Says ELX-02 Data Showed Increases In Key Metric

Proteostasis Therapeutics Rallies After Cystic Fibrosis Drug Is Granted Orphan Designation

Proteostasis Therapeutics Rallies On Genentech Licensing Agreement

Proteostasis Therapeutics Shares Surge On Positive Preliminary Cystic Fibrosis Trial Results

3 Reasons To Like Vertex Pharma Shares

More Than 30% Upside Seen For Vertex Stock On The Heels Of Phase 2 Data

Corbus Pharma's Positive Phase 2 Study: Safety First

Here's Why Shares Of Vertex Pharmaceuticals Tumbled

Goldman Comments On Vertex Pharmaceuticals Following FDA Approval

Cystic Fibrosis Market is Forecast to Show Positive Growth until 2017